S. M. Lippman

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

22h-index4.2kcitations61works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(18), Head and Neck Cancer Studies(15), Retinoids in leukemia and cellular processes(8), Cancer Diagnosis and Treatment(5), Lung Cancer Diagnosis and Treatment(4)

Publications61 total

Randomized trial of a short course of erlotinib 150 to 300 mg daily prior to surgery for squamous cell carcinomas of the head and neck (SCCHN) in current, former, and never smokers: Objective responses and clinical outcomes.

8 cited

Journal of Clinical Oncology·2011· 8 cited

DNA methyltransferase-3B (DNMT3B) in oral cancer (OC) development.

2 cited

Journal of Clinical Oncology·2011· 2 cited

Biologic risk model for recurrence in resected early-stage non-small cell lung cancer (ES NSCLC).

5 cited

Journal of Clinical Oncology·2011· 5 cited

Do elderly chemorefractory NSCLC patients derive benefit from salvage targeted therapy? Subgroup analysis of clinical outcome and toxicity from the BATTLE trial.

1 cited

Journal of Clinical Oncology·2011· 1 cited

Updated clinical and biomarker results from a phase I study of vandetanib with radiation therapy (RT) with or without cisplatin in locally advanced head and neck squamous cell carcinoma (HNSCC).

6 cited

Journal of Clinical Oncology·2011· 6 cited

The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival

63 cited

Annals of Oncology·2011· 63 citedOpen Access

PET/CT-guided Involved-field Intensity Modulated Radiation Therapy for Limited-stage Small Cell Lung Cancer

3 cited

International Journal of Radiation Oncology*Biology*Physics·2010· 3 cited

Phase I study of intermittent dosing of OSI-906, a dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF- 1R) and insulin receptor (IR) in patients with advanced solid tumors.

37 cited

Journal of Clinical Oncology·2010· 37 cited

Use of telomere length in peripheral leukocytes to predict risk of recurrence in patients with early-stage non-small cell lung cancer after curative resection.

Journal of Clinical Oncology·2010

Human papillomavirus (HPV) transmission from oropharyngeal cancer patients to sexual partners.

1 cited

Journal of Clinical Oncology·2010· 1 cited

Gene expression profiling of oral preneoplastic lesions (OPL) from a prospective prevention trial.

Journal of Clinical Oncology·2010

Genetic variants in the telomere maintenance pathway as predictors of second primary tumors and recurrence of early-stage head and neck cancer.

Journal of Clinical Oncology·2010

Evaluation of Src Tyr419 as a predictive biomarker in a neoadjuvant trial using dasatinib in resectable malignant pleural mesothelioma.

8 cited

Journal of Clinical Oncology·2010· 8 cited

Non-small cell lung cancer (NSCLC) in patients under 50: A long-term follow-up from the M. D. Anderson Cancer Center tumor registry.

Journal of Clinical Oncology·2010

Phase I evaluation of vandetanib with radiation therapy (RT) ± cisplatin in previously untreated advanced head and neck squamous cell carcinoma (HNSCC)

9 cited

Journal of Clinical Oncology·2009· 9 cited

Preliminary activity in adrenocortical tumor (ACC) in phase I dose escalation study of intermittent oral dosing of OSI-906, a small-molecule insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase inhibitor in patients with advanced solid tumors

20 cited

Journal of Clinical Oncology·2009· 20 cited

Nutritional Prevention of Cancer: New Directions for an Increasingly Complex Challenge

28 cited

JNCI Journal of the National Cancer Institute·2009· 28 citedOpen Access

Minimally increased risk of cerebrovascular occlusive disease or intracerebral hemorrhage in patients on bevacizumab treatment and association with intracerebral malignancies

3 cited

Journal of Clinical Oncology·2008· 3 cited

Profiling of cytokines and angiogenic factors (C/AF) in head and neck (HN) cancer correlates circulating biomarkers with clinical outcomes following induction chemotherapy

3 cited

Journal of Clinical Oncology·2008· 3 cited

Associations between genetic polymorphisms and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with paclitaxel-based therapy

Journal of Clinical Oncology·2008

page 1 of 4Next →

Frequent Co-authors

Waun Ki Hong(6), J. Jack Lee(6), W. K. Hong(6), V. Papadimitrakopoulou(6), Steven E. Benner(6), Waun Ki Hong(5), Gary L. Clayman(4), Ignacio I. Wistuba(4), R. Lotan(3), I. H. Krakoff(3), J. J. Kavanagh(3), M. Paredes-Espinoza(3), Dong M. Shin(3), A. K. El-Naggar(3), Bonnie S. Glisson(3), Lawrence E. Ginsberg(3), William N. William(3), Martin H. Huber(3), Loretta M. Itri(2), Daniel D. Karp(2)